UK consumers scaled back on food and alcohol purchases during the recent holiday season, a trend attributed by retail experts to the increasing popularity of weight loss injections. Despite a 2.5% increase in total grocery sales reaching £19.6 billion for the four weeks ending December 27, sales volume dipped by 0.2%.
Experts suggest that the decline in food and alcohol sales is linked to the growing use of GLP-1 injections, which simulate a hormone that induces a feeling of fullness in the body. Recent data from University College London estimates that approximately 1.6 million adults in the UK have used these injections in the past year.
Notably, the NHS prescribes weight loss injections like Mounjaro and Wegovy for weight management and Ozempic for diabetes treatment. This shift in consumer behavior has prompted retailers to adjust their product offerings to cater to a trend of more mindful and controlled consumption habits.
Retail analyst Jonathan De Mello remarked on the impact of GLP-1 usage on grocery sales, noting a decline in high-calorie categories such as snacks and alcohol. The introduction of smaller meal options by major retailers like Co-op, Marks & Spencer, and Iceland further underscores the shift towards healthier eating choices.
Acknowledging the influence of weight loss medications on consumer preferences, industry leaders like Greggs, Tesco, and Sainsbury’s are closely monitoring changing market dynamics. Greggs’ CEO highlighted a demand for smaller portions and nutritional information, prompting adjustments to their product range to meet evolving customer needs. Tesco’s CEO emphasized the importance of staying attuned to consumer trends, while Sainsbury’s CEO highlighted the importance of observing shifting shopping behaviors.